Effects of beta-endorphin on plasma glucose levels

• Autorzy: Akalin P P , Baspinar N.
• Języki publikacji: EN

Abstrakty

EN

Healthy, and insulin-deficient (streptozotocin-induced diabetic, STZ) Sprague-Dawley rats were used to investigate the effects of different doses of ß-endorphin (25 and 50 µg/kg) on plasma ß-endorphin, insulin, glucagon, and glucose levels at 15- and 30-min time points. In experimental groups, plasma ß-endorphin levels were higher at the 15-min than at the 30-min time point in healthy rats; however, in STZ-diabetic rats, ß-endorphin levels were lower at 15 min than at 30 min, indicating that intraperitoneal absorption of ß-endorphin differed between healthy and insulin-deficient rats, ß-endorphin did not affect plasma glucose, insulin, or glucagon at either dose in the healthy group. In the insulin-deficient rats, ß-endorphin at 50 µg/kg reduced plasma glucose levels at the 30-min time point compared to the 25 µg/kg dose, without affecting plasma insulin. Moreover, ß-endorphin at 50 µg/kg decreased plasma glucagon levels at the 15-min time point in comparison to the 25 µg/kg dose in insulin-deficient rats. Plasma glucose levels may be reduced in insulin-deficient rats at high ß-endorphin levels regardless of insulin status.

Słowa kluczowe

PL

rat; diabetes mellitus; beta-endorphin; glucose; insulin; glucagon; plasma glucose level

• Wydawca: -
• Czasopismo: Bulletin of the Veterinary Institute in Puławy
• Rocznik: 2010
• Tom: 54
• Numer: 2
• Opis fizyczny: p.277-282,ref.

Twórcy

autor

Akalin P P

• University of Selcuk, 42075 Konya, Campus, Turkey

autor

Baspinar N.

Bibliografia

• 1. Angelogianni P., Li H.L., Gianoulakis C.: Ontogenesis of proopiomelanocortin and its processing to ß-endorphin by the fetal and neonatal rat brain. Neuroendocrinology 2000, 72, 231-241.
• 2. Anonymous: www.ctf.istanbul.edu.tr/farma/pankreas.pdf
• 3. Anonymous: www.bachem.com/bachem/bachem/joust/index.cfm?idlan d=216.
• 4. Bouix O., Lenoir A.N., Kerdelhue B., Orsetti A.: Endogenous opioid peptides stimulate post-exercise insulin response to glucose in rats. Int J Sports Med 1996, 17, 80-84.
• 5. Carayannopoulos M.O., Chi M.M.Y., Cui Y., Pingsterhaus J.M., McKnigth R.A., Mueckler M., Devaskar S.U., Moley K.H.: GLUT 8 is a glucose transporter responsible for insulin stimulated glucose uptake in the blastocytes. Proc Natl Acad Sci USA 2000, 97, 7313-7318.
• 6. Cardoso A., Carvalho C.R.O., Velloso L.A., Brenelli S.L., Saad M.J.A., Carvalheira J.B.C.: Effect of thiopental and dietyl ether on early steps of insulin action in liver and muscle of the intact rat. Life Sci 2005, 76, 2287-2297.
• 7. Cheng J.T., Haung C.C., Liu I.M., Tzeng T.F., Chang C.J.: Novel mechanism for plasma glucose-lowering action of metformin in streptozotocin-induced diabetic rats. Diabetes 2006, 55, 819-825.
• 8. Cheng J.T., Liu I.M., Tzeng T.F., Chen W.C., Hayakawa S., Yamamoto T.: Release of ß-endorphin by caffeic acid to lower plasma glucose in streptozotocin-induced diabetic rats. Horm Metab Res 2003, 35, 251-258.
• 9. Chou H.F., McGivern R., Berman N., Ipp E.: Oscillations of circulating plasma insulin concentrations in the rat. Life Sci 1991, 48, 1463-1469.
• 10. Debold C.R., Nickolson W.E., Orth D.N.: Immunoreactive POMC peptides and POMC-like messenger ribonucleic acid are present in many rat non-pituitary tissues. Endocrinology 1988, 122, 2648-2657.
• 11. Evans A.A.L., Khan S., Smith M.E.: Evidence for s hormonal action of ß-endorphin to increase glucose uptake in resting and contracting skeletal muscle, J Endocrinol 1997, 155, 387-392.
• 12. Fatouros I., Goldfarb A.H., Jamurtas A.Z., Gao J.: ß- endorphin infusion alters pancreatic hormone and glucose levels during exercise in rats. Eur J Physiol 1997, 76, 203- 208.
• 13. Forman L.J., Estlilow S., Lewis M., Vasilenko P.: Streptozocin diabetes alters immunoreactive ß-endorphin levels and pain perception after 8 week in female rats. Diabetes 1986, 35, 1309-1313.
• 14. Forman L.J., Marquis D.E., Stevens R., Adler R., Vasilenko P.: Diabetes induced by streptozotocin results in a decrease in immunoreactive ß-endorphin levels in the pituitary and hypothalamus of female rats. Diabetes 1985, 34, 1104-1107.
• 15. Guigliano D., Cozzolino D., Salvatore T., Ceriello A., Torella R.: Dual effects of ß-endorphin on insulin secretion in man. Horm Metab Res 1987, 19, 502-503.
• 16. Guigliano D., Cozzolino D., Salvatore T., Ceriello A., Torella R., Franchimont P., Lefebvre P., Donofrio F.: Physical elevations of plasma ß-endorphin alter glucose metabolism in obese, but not normal-weight subjects. Metabolism 1992, 41, 184-190.
• 17. Helman A., Giraud P., Nicolaidis S., Oliver C., Assan R.: Glucagon release after stimulation of the lateral hypothalamic area in rats: predominant ß-adrenergic transmission and involvement endorphin pathways. Endocrinology 1983, 113, 1-5.
• 18. Hemmings S.J., Spafford D.: Neonatal STZ model of type II diabetes mellitus in the Fischer 344 rats: characteristics and assessment of the status of the hepatic adrenergic receptors. Int J Biochem Cell Biol 2000, 32, 905-919.
• 19. Hinz M., Katsilambros N., Maier V., Schatz H., Pfeiffer E.F.: Significance of streptozotocin induced nicotinamide-adenine dinucleotide (NAD) degradation in mouse pancreatic islands. FEBS Letters 1973, 30, 225- 228.
• 20. Houghten R.A., Swann R.W., Li C.H.: ß-endorphin: stability, clearence behavior and entry into the central nervous system after intravenous injection of the tritiated peptide in rats and rabbits. Proc Natl Acad Sci USA 1980, 77, 4588-4591.
• 21. Hsu C.T., Liu I.M., Cheng J.T.: Increase of ß-endorphin biosynthesis in the adrenal gland of streptozotocin- induced diabetic rats. Neurosci Letters 2002, 318, 57-60.
• 22. James D.E., Brown R., Navarro J., Pilch P.F.: Insulin regulatable tissues express a unique insulin-sensitive glucose transport protein. Nature 1988, 333, 183-185.
• 23. Jones R.G., Ilic V., Williamson D.H.: Physiological significance of altered insulin metabolism in the conscious rat during lactation. Biochemic J 1984, 220, 455-460.
• 24. Khawaja X., Green I.C., Thorpe J.R., Titheradge M.A.: The occurrence and receptor specifity of endogenous opioid peptides within pancreas and liver of the rat. Biochem J 1990, 267, 233-240.
• 25. Khawaja X., Gren I.: Dual action of ß-endorphin on insulin release in genetically obese and lean mice. Peptides 1991, 12, 227-233.
• 26. Klip A., Walker D., Ransome K.J., Schroer D.W., Leinhard G.E.: Identification of the glucose transporter in rat skeletal muscle. Arch Biochem Biophys 1983, 226, 198-205.
• 27. Kubik R.B., Shippenberg T.S., Herz A.: Involvement of central mu and delta opioid receptors in mediating the reinforcing effects of ß-endorphin in the rat. Eur J Pharmacol 1990, 175, 63-69.
• 28. Liu I.M., Chi T.C., Chen Y.C., Lu F.H., Cheng J.T.: Activation of opioid µ-receptor to lower plasma glucose in streptozotocin-induced diabetic rats. Neurosci Letters 1999, 265, 183-186.
• 29. Liu I.M., Niu C.S., Kuo D.H., Cheng J.T.: Investigations of the mechanism of the reduction of plasma glucose by cold-stress in streptozotocin-induced diabetic rats. Neuroscience 1999, 92, 1137-1142.
• 30. Liu M., Chen W.C., Cheng J.T.: Mediation of ß- endorphin by isoferulic acid to lower plasma glucose in streptozotocin-induced diabetic rats. J Pharmacol Exp Ther 2003, 307, 1196-1204.
• 31. Liu I.M., Cheng J.T.: Mediation of endogenous ß- endorphin in the plasma glucose-lowering action of herbal products observed in type 1-like diabetic rats. eCAM 2008, pp. 1-9.
• 32. Masiello P., Karunanayake E.H., Bergamini E., Hearse D.J., Mellows G.: ¹²C-streptozotocin: its distribution and interaction with nucleic acids and proteins. Biochem Pharmacol 1981, 30, 1907-1913.
• 33. Murray R.K.: Pituiter ve hipotalamik hormonlar, 'Harper'in Biyokimyası', Ed: Murray R.K., Mayes P., Granner D., Rodwell V., Barış Kitabevi Yayım ve Dağıtım, Cerrahpaşa, Ĭstanbul, 1993, pp. 603-604.
• 34. Ohara N.: Impaired intestinal active calcium absorption and reduction of serum 1 alpha, 25(OH)2D3 in streptozotocin induced diabetic pregnant rats with hypocalcemia in their fetuses. Clin Exp Obstet Gynecol 2000, 27, 100-102.
• 35. Pessin J.E., Bell G.: Mammalian facilitative glucose transporter family. Structure and molecular regulation. Ann Rev Physiol 1992, 54, 911-930.
• 36. Rogers S., Macheda M., Docherty S.E., Carty M.D., Henderson M.A., Soeller W.C., Gibbs E.M., James D.E., Best J.D.: Identification of a novel glucose transporter-like protein-GLUT12. Am J Physiol Endocrinol Metab 2002, 283, 733-738.
• 37. Rubinstein M., Stein S., Udenfriend S.: Isolation and characterisation of opioid peptides from rat pituitary: ß- endorphin. Proc Natl Acad Sci USA 1977, 74, 4969-4972.
• 38. Sato H., Sugiyama Y., Sawada Y., Iga T., Hanano M.: Physiologically based pharmacokinetics of radioiodinated ß-endorphin in rats. Drug Metab Disp 1987, 15, 540-550.
• 39. Stanaway S.E.R.S., Gill G.V.: Protein glycosylation in diabetes mellitus: biochemical and clinical considerations. Pract Diab Int 2000, 17, 21-25.
• 40. Van Den Burg E.H., Metz J.R., Arends R.J., Devreese B., Vandenberghe I., Van Beeumen J., Bonga S.E.W.: Identification of ß-endorphins in the pituitary gland and blood plasma of common carp (Cyprians carpio). J Endocrinol 2001, 169, 271-280.
• 41. Watkins W.B., Bruni J.F., Yen S.S.C.: ß-endorphin and somatostatin in the pancreatic D-cell colocalization by immunocytochemistry. J Histochem Cytochem 1980, 28, 1170-1174.
• 42. Watt M.J., Hargreaves M.: Effect of epinephrine on glucose disposal during exercise in humans: role of muscle glycogen. Am J Physiol Endocrinol Metab 2002, 283, 578-583.
• 43. Way W.L., Hosobuchi Y., Johnson B.H., Eger E.I., Bloom F.E.: Anesthesia does not increase opioid peptides in cerebrospinal fluid of humans. Anesthesiology 1984, 60, 43-45.
• 44. Wiesner J.B., Robert M.: Behavioral specificity of ß- endorphin suppression of sexual behavior: differential receptor antagonism. Pharmacol Biochem Behav 1986, 24, 1235-1239.
• 45. Yamamoto H., Uchigata Y., Okamoto H.: Streptozotocin and alloxan induced DNA strand breaks and poly (ADP_RIBOSE) synthetase in pancreatic islets. Nature 1981, 294, 284-286.
• 46. Young E., Houghten R.A., Akil H.: Degradation of [³H] ß-endorphin in rat plasma is increased with chronic stress, Eur J Pharmacol 1989, 167, 229-236.
• 47. Yu B.C., Chang C.K., Su C.F., Cheng J.T.: Mediation of ß-endorphin in andrographolide-induced plasma glucose lowering action in type I diabetes-like animals. Naunyn- Schmiedebergs Arch Pharmakol 2008, 377, 529-540.